Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Previously Treated Metastatic Colorectal Cancer
NCT00077987Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sunitinib in metastatic colorectal cancer (mCRC), sponsored by Pfizer. Started Dec 2003; status: completed.
02
Drugs
sunitinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00077987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077987.